Left: the EGFR pathway; Right: inhibition of the EGFR pathway by the EGFR monoclonal antibodies
Left: the EGFR pathway; Right: inhibition of the EGFR pathway by the EGFR monoclonal antibodies
Publication
KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies. (2010) D. Soulières, et al. Curr Oncol. 2010 Jul;17(Suppl 1):S31-S40. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TGFa | TGFA | ncbigene_symbol | TGFA | 7039 |
| Homo sapiens | Primates | EGF | EGF | ncbigene_symbol | EGF | 1950 |
| Homo sapiens | Primates | EGFR | EGFR | ncbigene_symbol | EGFR | 1956 |
| Homo sapiens | Primates | KRAS | KRAS | ncbigene_symbol | KRAS | 3845 |
| Homo sapiens | Primates | KRAS | KRAS | ncbigene_synonym | NRAS | 4893 |
| Homo sapiens | Primates | eg.VEGF | EGVEGF | ncbigene_synonym | PROK1 | 84432 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|